Infection is a common complication of ANCA-associated vasculitis (AAV) that tends to develop within six months of diagnosis, and…
Articles by Patricia Inacio, PhD
The U.S. Food and Drug Administration (FDA) has approved Rituxan (rituximab), in combination with glucocorticoids, for…
In granulomatosis with polyangiits (GPA) patients, the levels of anti-neutrophil cytoplasmic autoantibodies (ANCAs) — the autoantibodies associated with…
Almost half of patients diagnosed with ANCA-associated vasculitis (AAV) showed neurological symptoms in a single-site, retrospective study from India. But…
ANCA-associated vasculitis (AAV) patients with renal involvement have higher blood levels of certain small vesicles than either patients without…
Researchers say an important clinical assessment is determining whether ANCA-associated vasculitis patients who need dialysis at disease onset, due…
Levels of rheumatoid factor — an antibody against healthy tissue found in some autoimmune diseases — appear to separate…
Determining the levels of interleukins in the blood, specifically IL-10 and IL-33, may help identify people with early systemic…
Cardiac tamponade, the buildup of fluid in the space surrounding the heart, revealed a case of eosinophilic granulomatosis with…
People with ANCA-associated vasculitis (AAV) experience much worse fatigue than the general population, and although this eases in…